GGrantIndex
Sort

21,281 grants matching influenza

Epitope-targeted Vaccines for HIV-1 Prevention

$2,135,189
Xiangpeng Kong · New York University School Of Medicine · P01 · FY2014 · AI

Task V32: Manufacture of Influenza Virus Human Challenge Material for Phase I/II Clinical Testing

$2,131,382
Sangeetha Sagar · International Aids Vaccine Initiative · N01 · FY2024 · AI

Adeno-associated Virus Biology And Utilization For Gene Transfer

$2,128,065
John A Chiorini · National Institute Of Dental & Craniofacial Research · ZIA · FY2015 · DE

Discovery of agents that induce exosomes with adjuvant activity

$2,127,659
Dennis Carson · University Of California, San Diego · N01 · FY2019 · AI

Small-molecule adjuvants testing pipeline (Influenza)

$2,127,305
Ofer Levy · Boston Children'S Hospital · N01 · FY2022 · AI

T Cell Memory to Pathogens: Generation and Function

$2,126,315
Susan L Swain · Univ Of Massachusetts Med Sch Worcester · P01 · FY2010 · AI

IL-2 Family Cytokines and their Receptors-- Biology of the IL-2 system

$2,125,666
Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL

Immunobiology and Virology of Influenza A Virus

$2,123,866
Jonathan W Yewdell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

Structure based design of antibodies and vaccines

$2,122,980
James E Crowe · Vanderbilt University Medical Center · U19 · FY2017 · AI

Development/production of H3/H1 influenza DNA plasmid vaccine

$2,119,938
Kimberly Wallace · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Immune Function and Biodefense in Children, Elderly, and the Immunocrompromised

$2,119,503
Janko Nikolich-Zugich · Oregon Health & Science University · N01 · FY2010 · AI

Emerging Infections Program

$2,118,106
Paul R Cieslak · Public Health Services · U01 · FY2011 · CI

Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.

$2,117,028
Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

T cell Development and Regeneration

$2,116,341
Avinash Bhandoola · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Characterization of novel genes encoded ty RNA and DNA viruses

$2,115,911
Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2015 · AI

Disease Modeling of Influenza and Other Emerging Respiratory Viral Pathogens

$2,115,203
Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Membrane Remodeling in Viral Infection, Muscular Dystrophy, Parasite Invasion, and Traumatic Brain Injury

$2,115,091
Joshua Zimmerberg · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD

CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

$2,110,609
Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2020 · AI

Pandemic influenza DNA vaccine Development

$2,109,388
Lawrence R Smith · Vical, Inc. · U01 · FY2008 · AI

Immunobiology, molecular virology and countermeasures of highly pathogenic viruses

$2,104,975
Andrea Marzi · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Characterization of novel genes encoded ty RNA and DNA viruses

$2,102,641
Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2014 · AI

Emulating Immune Dysregulation by Trisomy 21 in a Multi-Organ-on-a-Chip System

$2,101,852
Kambez Hajipouran Benam · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · HL

Maternal and infant immunization to eliminate breast milk transmission of HIV-1

$2,101,177
Sallie R. Permar · Duke University · P01 · FY2019 · AI

Structure-function analysis of infection- and vaccine-induced B-cell repertoires

$2,100,193
Stephen C Harrison · Boston Children'S Hospital · P01 · FY2013 · AI

Virus-induced Cell Fate Decisions in Anti-Viral Immunity

$2,100,001
Troy D Randall · University Of Alabama At Birmingham · U19 · FY2014 · AI